oral birth control and semaglutide How GLP-1s Impact FDA Approves Oral Semaglutide as

June 12, 2025

The manufacturer's stability data shows semaglutide maintains full potency for up to 28 days once opened when kept at the correct refrigeration range

Semaglutide and liraglutide, two leading GLP-1 drugs, demonstrated significant weight reduction in clinical trials, with semaglutide achieving up to 15% body weight loss over 68 weeks

For research protocols requiring precise pharmacokinetic tracking of retatrutide plasma levels, the injection site should be standardized and documented consistently across study subjects and time points

Average weight loss was under 4% for those who stopped treatment early, versus nearly 7% or those who stopped later on, the study says

The expected timing, dose-matching logic, and washout considerations are covered in switching from tirzepatide to retatrutide